GALNT6 and gastric cancer: In a public gastric cancer dataset derived from Kaplan–Meier Plotter (http://kmplot.com/analysis) database, gastric cancer patients with higher expression of NONO (P = 1.1 × 10–8), c-Myc (P = 1.1 × 10–3), GALNT2 (P = 1.8 × 10–4), GALNT6 (P = 4.6 × 10–2), MGAT1 (P = 7.4 × 10–11), or hnRNPU (P = 8.5 × 10–7) had lower survival possibility (Fig. 8d).